Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03529942 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee
A Phase 3 study of Osteoarthritis, Knee, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 129
- Enrollment target
- 10
- Study locations
NCT03529942 is a Phase 3 study of Osteoarthritis, Knee that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 129 participants, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (78% lower). The trial reports 10 study locations across 7 states.
The verdict
NCT03529942, a Phase 3 study of Osteoarthritis, Knee, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 129 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is an open-label study assessing the effect of the administration of a single intra-articular (IA) injection of FX006 32 mg on synovial volume in patients with osteoarthritis (OA) of the knee.
Conditions Studied
Interventions
- DRUG FX006 32 mg
Study Locations (10)
California
- TriWest Research Associates, LLC - El Cajon
- Biosolutions Research - La Mesa
- Dream Team Clinical Research (formerly located in Anaheim) - Pomona
- Dream Team Clinical Research - Pomona
Florida
- Tampa Bay Medical Research, Inc. - Clearwater
Illinois
- Rush University Medical Center - Chicago
North Carolina
- Duke University Medical Center - Durham
Pennsylvania
- Altoona Center for Clinical Research - Duncansville
Tennessee
- PMG Research, Inc. d/b/a PMG Research of Knoxville - Knoxville
Other
- University of Leeds - Leeds
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2018-04-24 |
| Est. Completion | 2020-03-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03529942
The ClinicalTrials.gov registry entry for NCT03529942 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (78% lower). The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which FX006 32 mg is the first listed.
NCT03529942 reports 10 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT03529942 about?
NCT03529942 is a clinical study titled "Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee". This is an open-label study assessing the effect of the administration of a single intra-articular (IA) injection of FX006 32 mg on synovial volume in patients with osteoarthritis (OA) of the knee.
What is the current status of trial NCT03529942?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 129 participants. The study started on 2018-04-24. Estimated completion is 2020-03-09.
What conditions does trial NCT03529942 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT03529942?
The interventions under investigation include: FX006 32 mg (DRUG).
Who is sponsoring clinical trial NCT03529942?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03529942 being conducted?
This trial has 10 study locations across California, Florida, Illinois, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
RECRUITING · Phase 3
-
Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans
RECRUITING · Phase 3
-
A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
ACTIVE NOT RECRUITING · Phase 3
-
Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
ACTIVE NOT RECRUITING · Phase 3
-
Civamide in OA of the Knee(s)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.